Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.
O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D.
O'Connor S, et al. Among authors: pellegrini l.
Cureus. 2025 Jan 29;17(1):e78171. doi: 10.7759/cureus.78171. eCollection 2025 Jan.
Cureus. 2025.
PMID: 39882198
Free PMC article.